People in Northern Ireland have played a key role in the development of a new COVID-19 vaccine, Novavax, as part of a UK-wide trial.
Researchers at Queen’s University have completed recruitment of patients to a UK-wide clinical trial that is assessing the safety of an innovative cell therapy for COVID-19 patients with acute respiratory failure.
Queen’s University Belfast has been awarded a grant from Science Foundation Ireland and the Northern Ireland Department for the Economy to research how COVID-19 damages blood vessels.
1,000 children from Northern Ireland, Scotland, England and Wales, known as ‘COVID Warriors’ have had their levels of SARS-CoV-2 antibodies measured during the first wave of the pandemic and repeated again two months after initial recruitment.
A new clinical trial led by Queen’s University Belfast will investigate different drugs for helping airway clearance in critically ill patients who are on mechanical ventilators.
A team of scientists at Queen’s University have discovered a gene that increases the risk of blood vessel damage in people with diabetes. Switching off this gene could help people with diabetes live longer, healthier lives.
Dr David Courtney, from Wellcome-Wolfson Institute for Experimental Medicine is one of 436 laureates from the 2020 ERC Starting Grants competition who have been awarded a share of €677 million to tackle the biggest scientific questions of our time.
Over 1,000 children from Northern Ireland, Scotland, England and Wales, known as ‘COVID Warriors’ have had their antibodies measured in the UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’.
A research team led by Queen’s, in collaboration with the Center for Regenerative Therapies, Dresden, has found how a specific protein plays a crucial role in the generation of neurons at a specific time and location during brain development.
A project at Queen’s University Belfast aiming to develop a new method of making grafted blood vessels more resilient has been awarded a grant of over £145,000 by national charity Heart Research UK.
Researchers at Queen’s are working as part of the COVID-19 Genomics UK Consortium (COG-UK), which has been backed by a £20 million investment from government to perform whole genome sequencing of the SARS-CoV2 virus.
Queen’s University Belfast is leading a UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’ to measure antibodies to SARS-CoV-2 (COVID-19) in healthy children.
A team of researchers from Queen’s University have identified new problems linked to the disease and warn of a sharp rise in antimicrobial resistance associated to COVID-19 treatments in the aftermath of the pandemic.
Queen’s University Belfast has received funding to conduct a trial with the aim of developing a rapid diagnostic test for COVID-19.
A new clinical trial led by Queen’s University Belfast and the University of Warwick seeks to find alternatives to ventilators to treat patients who are critically ill with COVID-19.
Researchers at the Wellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast have been awarded a grant of £295,626 in a bid to find an urgently-needed treatment for COVID-19.
Researchers at Queen’s University Belfast have been involved in ground-breaking research that holds promise for a vast majority of those with cystic fibrosis.
Scientists at Queen’s University have been awarded a prestigious grant by British Heart Foundation Northern Ireland (BHF NI) to investigate how heart cells change in people affected by an abnormal heart rhythm.
Cells produced in the human body could be used to heal damaged blood vessels according to new research at Queen's University Belfast, which has recently been published in the journal, Cardiovascular Research.
A discovery by researchers at Queen’s University Belfast and King’s College London (KCL) could revolutionise treatment for vascular and diabetes related cardiovascular diseases.
Researchers from Queen’s University Belfast have discovered a new way of treating major diseases of the eye caused by the abnormal growth of new blood vessels.
Researchers at Queen’s University Belfast have discovered a novel experimental treatment for chronic lung diseases that could improve the lives for people with Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD).
With a better understanding of how Klebsiella Pneumoniae evades our body's immune system, researchers with the EU-funded U-KARE project are developing new treatments based on boosting our defences against the potentially deadly disease.
New research show that calcified nodules in the eye increase the risk for progression to advanced AMD more than six times
An iconic and world class building, the Wellcome-Wolfson Institute for Experimental Medicine, has been opened at Queen’s University Belfast.
Queen’s University Belfast will hosting AIMday Big Data, AI and the One Health Agenda on Friday 19th October 2018 at Riddel Hall, Queen’s University Belfast.
In July 2018, four students from Mohammed Bin Rashid University (MBRU) in Dubai came to Belfast to spend four weeks at the Wellcome-Wolfson Institute for Experimental Medicine. Find out how they got on by watching our video.
Researchers from Queen’s University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer’s disease (AD).
A chance conversation between researchers at Queen’s University Belfast led to their combined expertise in developing a ground-breaking approach for the treatment of pneumonia.
To celebrate the NI Science Festival, we opened our doors on 17 February and invited you to join us to explore how the human body works and how we are leading the fight against disease.
Researchers from Queen’s University Belfast will investigate whether changes in certain genes in the heart can be used as a test to identify coronary heart disease – the UK’s biggest single killer.
Researchers at Queen’s University Belfast have discovered that aspirin could reverse the effects of tooth decay resulting in a reduction in the need for fillings. Currently about 7 million fillings are provided by the NHS each year in England alone.
Postgraduate Students in WWIEM held their annual symposia in April and May 2017. Each year organised their own symposium with guest speakers, trade stands from our leading suppliers and prizes for the best talks.
A new technology which could save thousands of lives in Intensive Care Units is being taken forward by researchers at Queen’s University Belfast in one of the biggest clinical trials in the world in the area of respiratory failure.
The European Commission has highlighted the significance of a multimillion pound research project, led by Queen’s University Belfast, in tackling multidrug resistant infections.
BBC News investigated the issue of post-polio syndrome, a neurological disease evident in people who had polio, and spoke to WWIEM's Dr Ultan Power on the subject.
Researchers have discovered why antibiotics for treating people with cystic fibrosis are becoming less effective and how fat soluble vitamins might offer a viable solution.
Wellcome-Wolfson Institute for Experimental Medicine researcher Dr Denise Fitzgerald has been interviewed by BBC News following publication of a paper that reveals a major discovery in the fight against Multiple Sclerosis.
Researchers at Queen’s University Belfast have discovered why a lethal superbug is so resistant to the last line antibiotic meaning potential treatments could now be developed to fight the killer infection.
An international team of researchers from Queen’s, University College London and the University of Alabama at Birmingham have developed a cell culture model that could help to develop earlier treatment strategies for AMD.
Scientists from across Europe who are leading the fight against superbugs will gather at Queen’s University Belfast next week (14-15 September 2016).
Researchers at Queen’s University Belfast have begun a £2 million research programme to investigate reversing the damage caused by Multiple Sclerosis.
Scientists at Queen’s are developing a potential revolutionary new treatment for Sepsis and Acute Respiratory Distress Syndrome (ARDS), which are among the leading causes of death in hospitalised patients in the UK.
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
World-leading researchers from Queen’s University Belfast are among a team of scientists from the USA and Ireland who are collaborating to develop a novel treatment for diabetes-related blindness.
A ground-breaking new drug combination that could prolong the lives of cystic fibrosis patients, has been trialled by researchers at Queen’s University Belfast.